JLE

Epileptic Disorders

MENU

Epilepsy and clinically latent cerebrovascular disease Volume 24, issue 3, June 2022

  • [1.] Cvetkovska E, Babunovska M, Boskovski B, Kuzmanovski I, Tanovska N, Trencevska GK. Prevalence of various risk factors associated with new-onset epilepsy after the age of 50: a retrospective population-based study. Epileptic Disord 2022; 24(1): 95-101.
  • [2.] Stefanidou M, Himali JJ, Devinsky O, Romero JR, Ikram MA, Beiser AS, et al. Vascular risk factors as predictors of epilepsy in older age: the Framingham Heart Study. Epilepsia 2022; 63(1): 237-43.
  • [3.] National High Blood Pressure, Program. The seventh report of the joint national committee on prevention, detection, evaluation. In: Evaluation and treatment of high blood pressure. Bethesda (MD): National Heart, Lung, and Blood Institute (US), 2004.
  • [4.] Nam K-W, Kwon H-M, Jeong H-Y, Park J-H, Kwon H, Jeong S-M. Cerebral small vessel disease and Stage 1 hypertension defined by the 2017 American College of Cardiology/ American Heart Association guidelines. Hypertension 2019; 73(6): 1210-6.
  • [5.] Agabiti-Rosei E, Rizzoni D, Cunha P. Pathophysiology of brain damage in hypertension: small vessel disease. In : Coca A, ed. Hypertension and brain damage. Switzerland: Springer.
  • [6.] Petrea RE, O’Donnell A, Beiser AS, Habes M, Aparicio H, DeCarli C, et al. Mid to late life hypertension trends and cerebral small vessel disease in the Framingham Heart Study. Hypertension 2020; 76(3): 707-14.
  • [7.] Cimolai N. Cerebrovascular disease integration of chronic kidney disease and hypertension. J Stroke Cerebrovasc Dis 2020; 30(10): 105519.
  • [8.] Neutel JM, Smith DHG. Familial aspects of the hypertension syndrome. J Cardiovasc Risk 1997; 4(4): 243-9.
  • [9.] Sargurupremraj M, Suzuki H, Jian X, Sarnowski C, Evans TE, Bis JC, et al. Cerebral small vessel genomics and its implications across the lifespan. Nat Commun 2020; 11(1): 6285.
  • [10.] Garcia JH, Ho K-L. Pathology of hypertensive arteriopathy. Neurosurg Clin N Am 1992; 3(3): 497-507.
  • [11.] World Health Organization. Cerebrovascular disorders: a clinical and research classification. WHO, 1978. https://apps.who.int/iris/handle/10665/37194
  • [12.] Gronewold J, Jokisch M, Schramm S, Jockwitz C, Miller T, Lehmann N, et al. Association of blood pressure, its treatment, and treatment efficacy with volume of white matter hyperintensities in the population-based 1000BRAINS Study. Hypertension 2021; 78: 1490-501.
  • [13.] Elyas S, Adingupu D, Aizama K, Casanova R, Gooding K, Fulford J, et al. Cerebral small vessel disease, systemic vascular characteristics and potential therapeutic targets. Aging 2021; 13(18): 22030-9.